Matthew B. Klein Ptc Therapeutics, Inc. (PTCT) insider trading activity

PTCT Quotes by TradingView

Matthew B. Klein is CHIEF EXECUTIVE OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 283,830 shares of PTCT, which is worth approximately $12.8 Million. The most recent transaction as insider was on Jan 08, 2021, when has been sold 5,500 shares (Common Stock) at a price of $38.98 per share, resulting in proceeds of $214,390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 284K
25.7% 3M change
76.87% 12M change
Total Value Held $12.8 Million

Matthew B. Klein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2021
BUY
Exercise of conversion of derivative security
$214,390 $38.98 p/Share
5,500 Added 18.15%
24,809 Common Stock
Jan 07 2021
SELL
Open market or private sale
$268,056 $68.98 p/Share
3,886 Reduced 16.75%
19,309 Common Stock
Jan 07 2021
BUY
Exercise of conversion of derivative security
$151,476 $38.98 p/Share
3,886 Added 14.35%
23,195 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
9,000 Added 31.79%
19,309 Common Stock

Also insider at

CLPT
ClearPoint Neuro, Inc. Healthcare
Director
MBK

Matthew B. Klein

CHIEF EXECUTIVE OFFICER
South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTCT